Healing Electroceutical Dressing for the Recovery of Open Wounds (HERO)
Recruiting now · Not applicable
Conditions studied: Wound Heal, Wound Infection, Wound Healing Delayed, Wound of Skin, Infections
In brief
The goal of this clinical trial is to determine whether the wireless electroceutical dressing (WED) called PowerHeal™ Bioelectric Bandage, improves care of infected wounds by clearing the infection and helping the wound heal better. The main hypotheses it aims to answer are: 1. WED promotes wound closure, as determined by wound area measurement 2. WED manages wound infection in civilian and military wounds in Ukraine, as determined by clinical assessment of wound infection by measuring the numbers and types of relevant microbes. Researchers will compare to see if PowerHeal™ Bioelectric Bandage the dressing used in the SOC group Participants will get their dressings changed per the protocol, wound image and swab will be taken.
Key facts
- Study ID
- NCT07329114
- Run by
- Chandan Sen
- People needed
- 150
- Starts
- 2026-02-11
- Expected to finish
- 2027-08-01
- Last updated by the study team
- 2026-03-06
Who can join
Age: 18 and older, up to 105. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Female and male participants 18-105 years of age
- Hospital admission (or boarding in an emergency department or other area awaiting hospital admission) at participating clinical sites in Ukraine
- At least one infected traumatic wound(s) between 20-40 cm2 in size. Probable or confirmed wound infection(s) will be determined by on-site physicians' clinical judgment and the presence of two or more of the following clinical indicators of wound infection:
- Presence of worsening pain (from the moment of injury)
- Erythema (redness)
- Warmth (heat)
- Edema (swelling)
- Purulent exudate (drainage)
- Delayed healing
- Discoloration
- Friable granulation
- Foul odor
- Wound margin breakdown or necrosis with or without fever
- Pustules, vesicles, boils
- Participant or legal representative provides written informed consent prior to investigation procedures
- Participant understands and agrees to adhere to planned investigation procedures
You may not qualify if…
- Allergy to silver or zinc
- Women who are pregnant or nursing
- Women of childbearing potential without a documented negative pregnancy test during the current hospitalization or women of childbearing potential who refused pregnancy testing during screening
- Sponsor or contract research organization (CRO) staff directly involved in the conduct of the investigation, and site staff supervised by the investigator, and their respective family members
- > 60 days from the initial traumatic injury
- Known prisoner
- The patient is expected to be discharged from the hospital within the next 24 hours
- Medical condition other than the acute traumatic wound (and its manifestations) that is likely to result in death within 14 days of randomization
- Moribund condition, defined as life expectancy less than 48 hours from randomization
- Patients undergoing comfort care measures only such that treatment focuses on end-of-life symptom management over prolongation of life
- Expected inability or unwillingness to participate in study procedures
- In the opinion of the investigator, participation in the investigation is not in the best interest of the patient
- Note: Allergies to parabens and acrylates will also be considered. While they are not direct exclusions, participants with these allergies should avoid being enrolled.
Where it is running
- Ivano-Frankivsk Central Clinical Hospital — Ivano-Frankivsk, Ukraine (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.